EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Wnt/β-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes

Thomas A Kluiver iD, Anna Nordin iD, Yuyan Lu, Xuan Guo iD, Stephanie A Schubert, Darien Yeung, Arif Ibrahim Ardisasmita iD, Wessel Terpstra iD, Chang Zhang, Xiaochen Duan, Rishi Savur, Marius C van den Heuvel und 7 weitere

Proceedings of the National Academy of Sciences · 2026

DOI: 10.1073/pnas.2528450123 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2026. Verfasst von Thomas A Kluiver und 18 weiteren Autor:innen. Beteiligte Einrichtung: Princess Máxima Center for Pediatric Oncology, Utrecht 3584 CH, The Netherlands. Hauptthemen laut MEDLINE: beta Catenin, Transcription Factor 7-Like 2 Protein, Wnt Signaling Pathway, Lymphoid Enhancer-Binding Factor 1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: KIKA, Oncode Accelerator, Cancerfonden (Swedish Cancer Society).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The mechanisms by which Wnt/β-catenin signaling regulates gene expression in a tissue- and context-specific manner remain poorly understood, limiting our ability to target the aberrant cell growth typical of many Wnt-driven cancers. Here, we focus on malignant liver tumors driven by activating CTNNB1 (β-catenin) mutations that nevertheless display distinct phenotypic states and Wnt outputs. By profiling patient-derived organoids via single-cell transcriptomics and chromatin dynamics, we identify subtype-specific transcriptional and epigenetic profiles. Using CUT&RUN, we show that β-catenin engages distinct genomic regions, dictated by differential association with TCF/LEF family transcription factors. Specifically, we define a sequence-specific regulatory element engaged by β-catenin only upon interaction with TCF7L2, revealing that partner choice, independent of CTNNB1 mutational status, ultimately determines cell fate. Our findings, validated across multiple tumor models and patient tissues, offer a framework for understanding how differential β-catenin-TCF/LEF interaction orchestrates context-specific Wnt signaling outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta CateninTranscription Factor 7-Like 2 ProteinWnt Signaling PathwayLymphoid Enhancer-Binding Factor 1Liver NeoplasmsHumansPhenotypeGene Expression Regulation, NeoplasticAnimalsCell Line, TumorProtein BindingMutation

Stichwörter der Autor:innen

TCF/LEFWnt signalingcancernovel motifβ-catenin

Substanzen

beta CateninTranscription Factor 7-Like 2 ProteinTCF7L2 protein, humanLymphoid Enhancer-Binding Factor 1LEF1 protein, humanCTNNB1 protein, human

Autor:innen und Institutionen

  • Princess Máxima Center for Pediatric Oncology, Utrecht 3584 CH, The Netherlands.
  • Wallenberg Centre for Molecular Medicine, Linköping University, Linköping SE-581 83, Sweden.
  • Department of Biomedical and Clinical Sciences, Division of Molecular Medicine and Virology, Faculty of Medicine and Health Sciences, Linköping University, Linköping SE-581 83, Sweden.
  • Science for Life Laboratory, Linköping University, Linköping SE-581 83, Sweden.
  • Department of Oncology, Zhongshan Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361004, China.
  • Department of Surgery, Section of Hepatobiliary Surgery and Liver Transplantation, University of Groningen, University Medical Center Groningen, Groningen 9713 GZ, The Netherlands.

ORCID-Profile: Thomas A Kluiver, Anna Nordin, Xuan Guo, Arif Ibrahim Ardisasmita, Wessel Terpstra, Vincent E de Meijer, Ruben H de Kleine, József Zsiros, Claudio Cantù, Weng Chuan Peng

Förderung

  • KIKA
  • Oncode Accelerator
  • Cancerfonden (Swedish Cancer Society)
  • Swedish Research Council
  • Additional Ventures (AV)
  • Canadian Institutes of Health Research (CIHR)

Zitieren

APA

Kluiver, T. A., Nordin, A., Lu, Y., Guo, X., Schubert, S. A., Yeung, D., Ardisasmita, A. I., Terpstra, W., Zhang, C., Duan, X., Savur, R., van den Heuvel, M. C., de Meijer, V. E., de Kleine, R. H., Kraal, K., de Krijger, R. R., Zsiros, J., Cantù, C., & Peng, W. C. (2026). Differential Wnt/β-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2528450123

Vancouver

Kluiver TA, Nordin A, Lu Y, Guo X, Schubert SA, Yeung D, et al. Differential Wnt/β-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes. Proceedings of the National Academy of Sciences. 2026. doi:10.1073/pnas.2528450123

BibTeX
@article{Kluiver2026,
  author = {Kluiver, Thomas A and Nordin, Anna and Lu, Yuyan and Guo, Xuan and Schubert, Stephanie A and Yeung, Darien and Ardisasmita, Arif Ibrahim and Terpstra, Wessel and Zhang, Chang and Duan, Xiaochen and Savur, Rishi and van den Heuvel, Marius C and de Meijer, Vincent E and de Kleine, Ruben H and Kraal, Kathelijne and de Krijger, Ronald R and Zsiros, József and Cantù, Claudio and Peng, Weng Chuan},
  title = {Differential Wnt/β-catenin signaling via TCF7L2/LEF1 binding specificity shapes cellular and tumor phenotypes},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2026},
  doi = {10.1073/pnas.2528450123}
}
Kostenlos starten →